Abstract

Amphetamine (AMPH) and methamphetamine (METH) are widely abused psychostimulants, which produce a variety of psychomotor, autonomic and neurotoxic effects. The behavioral and neurotoxic effects of both compounds (from now on defined as AMPHs) stem from a fair molecular and anatomical specificity for catecholamine-containing neurons, which are placed in the brainstem reticular formation (RF). In fact, the structural cross-affinity joined with the presence of shared molecular targets between AMPHs and catecholamine provides the basis for a quite selective recruitment of brainstem catecholamine neurons following AMPHs administration. A great amount of investigations, commentary manuscripts and books reported a pivotal role of mesencephalic dopamine (DA)-containing neurons in producing behavioral and neurotoxic effects of AMPHs. Instead, the present review article focuses on catecholamine reticular neurons of the low brainstem. In fact, these nuclei add on DA mesencephalic cells to mediate the effects of AMPHs. Among these, we also include two pontine cholinergic nuclei. Finally, we discuss the conundrum of a mixed neuronal population, which extends from the pons to the periaqueductal gray (PAG). In this way, a number of reticular nuclei beyond classic DA mesencephalic cells are considered to extend the scenario underlying the neurobiology of AMPHs abuse. The mechanistic approach followed here to describe the action of AMPHs within the RF is rooted on the fine anatomy of this region of the brainstem. This is exemplified by a few medullary catecholamine neurons, which play a pivotal role compared with the bulk of peripheral sympathetic neurons in sustaining most of the cardiovascular effects induced by AMPHs.

Highlights

  • Amphetamine (AMPH) and mostly methamphetamine (METH) are widely abused psychostimulants, which possess a phenylethylamine structure

  • We focus on NE nuclei located within the lateral column of the bulbo-pontine reticular formation (RF) and a mixed neuronal population within the dorsal raphe/periaqueductal gray (PAG), which contains a subset of NE and DA neurons (Battenberg and Bloom, 1975; Saavedra et al, 1976; Steinbusch et al, 1981; Nieuwenhuys et al, 1988; Baker et al, 1990, 1991; Lu et al, 2006; Li et al, 2016; Bucci et al, 2017; Cho et al, 2017)

  • In addition to the presence of NE-containing neurons, the dorsal raphe receives a powerful NE innervation. This is supported by findings in humans, where the amount of NE transporter (NET) in the ventral nuclei of the dorsal raphe matches the amount of NET which can be measured within the Locus Coeruleus (LC) (Ordway et al, 1997)

Read more

Summary

INTRODUCTION

Amphetamine (AMPH) and mostly methamphetamine (METH) are widely abused psychostimulants, which possess a phenylethylamine structure. This allows NE to be released in the extracellular medium from each varicosity along the course of axon fibers to produce extra-synaptic, FIGURE 2 | An anatomical overview of the brainstem reticular formation (RF) This cartoon provides a synthetic overview of the neuroanatomy of brainstem RF nuclei in order to foster orientation within the brainstem when referring to the site-specificity of the effects induced by AMPHs. Monoamine-containing nuclei are placed in a quite restricted brain region corresponding to the median and lateral column of the brainstem RF. This is the case of the NE nucleus epicoeruleus, DA neurons of the A10dc nucleus, as well as cholinergic neurons of the laterodorsal tegmental nucleus (LDTg, Ch6), which intermingle in the ventral and ventrolateral PAG with their rostral extent (Hökfelt et al, 1984; Mai and Paxinos, 2012; Vasudeva and Waterhouse, 2014; Figure 7)

AMPHs and Catecholamine Neurons of the PAG
Findings
AUTHOR CONTRIBUTIONS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call